ELV
HealthcareElevance Health Inc.
$290.36+2.47 (+0.86%)
Prev Close
$287.89
Open
$291.32
High
$294.43
Low
$289.60
Volume
1.75M
Market Cap
$63.54B
P/E
11.53
Div Yield
0.02%
Over the past 12 months, insider activity at Elevance Health Inc. (ELV) has been mixed between buying and selling, with 3 insider purchases totaling $3.68M and 5 insider sales totaling $3.99M. The most recent insider transaction was by Kendrick Charles Morgan JR (officer: EVP & President, Commercial), who sold $910.6K worth of shares on Mar 9, 2026. Elevance Health Inc. operates in the Healthcare sector, within the Medical - Healthcare Plans industry, with a market cap of $63.54B.
Buys (12M)
3
$3.68M
Sells (12M)
5
$3.99M
Net Activity
Net Seller
$305.9K
Active Insiders
7
last 12 mo
ELV Price Chart
ELV Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026↗ | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | Sell | 3,196 | $284.92 | $910.6K | 11,791 |
| Mar 6, 2026↗ | COLLIS STEVEN H | director | Buy | 3,000 | $289.84 | $869.5K | 3,639 |
| Feb 3, 2026↗ | Craig Ryan R | EVP & Chief HR Officer | Sell | 279 | $341.83 | $95.4K | 0 |
| Oct 3, 2025↗ | Kaye Mark | EVP & CFO | Sell | 2,895 | $340.24 | $985.0K | 0 |
| Sep 5, 2025↗ | Wessling Erin M | EVP & Chief Legal Officer | Sell | 152 | $321.59 | $48.9K | 0 |
| Aug 21, 2025↗ | DeVore Susan D. | Director | Buy | 1,200 | $312.15 | $374.6K | 0 |
| Jul 18, 2025↗ | BOUDREAUX GAIL | President and CEO | Buy | 8,500 | $286.94 | $2.44M | 0 |
| Apr 25, 2025↗ | Kaye Mark | EVP & CFO | Sell | 4,588 | $424.82 | $1.95M | 0 |
| Mar 11, 2025↗ | Penczek Ronald W | CAO & Controller | Sell | 443 | $415.13 | $183.9K | 0 |
| Mar 5, 2025↗ | BOUDREAUX GAIL | President and CEO | Sell | 10,396 | $395.50 | $4.11M | 0 |
| Mar 5, 2025↗ | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 2,281 | $395.50 | $902.1K | 0 |
| Mar 5, 2025↗ | Kaye Mark | EVP & CFO | Sell | 270 | $395.50 | $106.8K | 0 |
| Mar 5, 2025↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 5,725 | $395.99 | $2.27M | 0 |
| Mar 5, 2025↗ | LAVU RATNAKAR | EVP, Chief Digital & Info Off | Sell | 312 | $395.50 | $123.4K | 0 |
| Mar 5, 2025↗ | Norwood Felicia F | EVP & President,Gov Health Ben | Sell | 2,613 | $395.50 | $1.03M | 0 |
| Mar 5, 2025↗ | Penczek Ronald W | CAO & Controller | Sell | 198 | $395.50 | $78.3K | 0 |
| Nov 1, 2024↗ | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 1,649 | $414.01 | $682.7K | 17,238 |
| Nov 1, 2024↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 846 | $414.01 | $350.3K | 7,577 |
| Oct 18, 2024↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 7,417 | $432.14 | $3.21M | 8,423 |
| Oct 2, 2024↗ | Kaye Mark | EVP & CFO | Sell | 2,818 | $505.16 | $1.42M | 20,213 |
| Aug 5, 2024↗ | PERU RAMIRO G | Director | Sell | 753 | $531.52 | $400.2K | 8,744 |
| Jul 22, 2024↗ | BOUDREAUX GAIL | President and CEO | Sell | 34,000 | $500.98 | $17.03M | 159,609 |
| Jul 19, 2024↗ | Dixon Robert L JR | Director | Sell | 305 | $506.76 | $154.6K | 9,721 |
| Apr 23, 2024↗ | Norwood Felicia F | EVP & President,Gov Health Ben | Sell | 20,310 | $533.34 | $10.83M | 31,560 |
| Mar 8, 2024↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 2,432 | $500.46 | $1.22M | 15,840 |
| Mar 6, 2024↗ | Penczek Ronald W | CAO & Controller | Sell | 916 | $504.58 | $462.2K | 1,764 |
| Mar 1, 2024↗ | BOUDREAUX GAIL | President and CEO | Sell | 19,256 | $499.11 | $9.61M | 117,777 |
| Mar 1, 2024↗ | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 25,409 | $500.00 | $12.70M | 35,776 |
| Mar 1, 2024↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 1,484 | $499.11 | $740.7K | 13,764 |
| Mar 1, 2024↗ | Norwood Felicia F | EVP & President,Gov Health Ben | Sell | 4,902 | $499.11 | $2.45M | 28,541 |
| Mar 1, 2024↗ | Penczek Ronald W | CAO & Controller | Sell | 383 | $499.11 | $191.2K | 1,408 |
| Mar 1, 2024↗ | Todt Blair Williams | EVP, CLO & CAO | Sell | 3,650 | $499.11 | $1.82M | 8,465 |
| Feb 7, 2024↗ | PERU RAMIRO G | Director | Sell | 753 | $500.00 | $376.5K | 9,109 |
| Jan 3, 2024↗ | Todt Blair Williams | EVP, CLO & CAO | Sell | 397 | $480.49 | $190.8K | 12,115 |
| Dec 14, 2023↗ | Todt Blair Williams | EVP, CLO & CAO | Sell | 5,492 | $484.02 | $2.66M | 12,512 |
| Dec 1, 2023↗ | Todt Blair Williams | EVP, CLO & CAO | Sell | 1,641 | $456.06 | $748.4K | 16,029 |
| Nov 30, 2023↗ | Penczek Ronald W | CAO & Controller | Sell | 1,055 | $475.17 | $501.3K | 1,787 |
| Nov 1, 2023↗ | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 154 | $446.66 | $68.8K | 17,739 |
| Nov 1, 2023↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 79 | $446.66 | $35.3K | 15,248 |
| Oct 24, 2023↗ | Penczek Ronald W | CAO & Controller | Sell | 64 | $454.35 | $29.1K | 2,842 |
| Jul 21, 2023↗ | Dixon Robert L JR | Director | Sell | 310 | $476.71 | $147.8K | 9,638 |
| Mar 24, 2023↗ | MCCARTHY GLORIA M | EVP & Chief Administrative Off | Sell | 15,098 | $444.76 | $6.71M | 65,933 |
| Mar 9, 2023↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 2,314 | $462.22 | $1.07M | 15,327 |
| Mar 1, 2023↗ | BOUDREAUX GAIL | President and CEO | Sell | 20,085 | $468.81 | $9.42M | 135,863 |
| Mar 1, 2023↗ | Gallina John E | EVP & Chief Financial Officer | Sell | 5,237 | $468.81 | $2.46M | 63,725 |
| Mar 1, 2023↗ | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 6,076 | $468.81 | $2.85M | 17,893 |
| Mar 1, 2023↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 1,377 | $468.83 | $645.6K | 17,641 |
| Mar 1, 2023↗ | MCCARTHY GLORIA M | EVP & Chief Administrative Off | Sell | 6,047 | $468.81 | $2.83M | 66,533 |
| Mar 1, 2023↗ | Norwood Felicia F | EVP & President, GBD | Sell | 5,249 | $468.80 | $2.46M | 33,443 |
| Mar 1, 2023↗ | Penczek Ronald W | CAO & Controller | Sell | 444 | $468.82 | $208.2K | 2,882 |
| Mar 1, 2023↗ | Todt Blair Williams | EVP and Chief Legal Officer | Sell | 372 | $469.03 | $174.5K | 7,911 |
| Dec 30, 2022↗ | Norwood Felicia F | EVP & President, GBD | Sell | 1,754 | $512.97 | $899.7K | 26,684 |
| Dec 1, 2022↗ | Todt Blair Williams | EVP and Chief Legal Officer | Sell | 117 | $525.25 | $61.5K | 4,300 |
| Nov 1, 2022↗ | Haytaian Peter D | EVP & Pres Carelon & IngenioRx | Sell | 200 | $544.53 | $108.9K | 11,961 |
| Nov 1, 2022↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 79 | $544.53 | $43.0K | 14,450 |
| Jun 9, 2022↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 6,328 | $488.60 | $3.09M | 18,657 |
| Jun 6, 2022↗ | Dixon Robert L JR | Director | Sell | 420 | $497.14 | $208.8K | 9,491 |
| May 18, 2022↗ | PERU RAMIRO G | Director | Sell | 990 | $468.88 | $464.2K | 9,405 |
| Mar 10, 2022↗ | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Sell | 17,703 | $460.70 | $8.16M | 27,694 |
| Mar 1, 2022↗ | BOUDREAUX GAIL | President and CEO | Sell | 16,997 | $452.66 | $7.69M | 120,639 |
| Mar 1, 2022↗ | Gallina John E | EVP & Chief Financial Officer | Sell | 4,575 | $452.58 | $2.07M | 57,601 |
| Mar 1, 2022↗ | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Sell | 5,160 | $452.65 | $2.34M | 28,016 |
| Mar 1, 2022↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 914 | $452.94 | $414.0K | 14,529 |
| Mar 1, 2022↗ | MCCARTHY GLORIA M | EVP & Chief Administrative Off | Sell | 5,358 | $452.59 | $2.42M | 60,731 |
| Mar 1, 2022↗ | Norwood Felicia F | EVP & President, GBD | Sell | 4,014 | $452.83 | $1.82M | 28,438 |
| Mar 1, 2022↗ | Penczek Ronald W | CAO & Controller | Sell | 2,844 | $462.10 | $1.31M | 2,766 |
| Mar 1, 2022↗ | Todt Blair Williams | EVP and Chief Legal Officer | Sell | 191 | $451.50 | $86.2K | 2,534 |
| Feb 7, 2022↗ | Penczek Ronald W | CAO & Controller | Sell | 2,763 | $453.48 | $1.25M | 2,012 |
| Dec 30, 2021↗ | Norwood Felicia F | EVP & President, GBD | Sell | 1,754 | $467.15 | $819.4K | 23,256 |
| Dec 30, 2021↗ | STARK LEAH | EVP & CHRO | Sell | 482 | $467.15 | $225.2K | 12,403 |
| Dec 1, 2021↗ | Todt Blair Williams | EVP and Chief Legal Officer | Sell | 79 | $404.65 | $32.0K | 2,725 |
| Oct 28, 2021↗ | Penczek Ronald W | SVP, Chief Accounting Officer | Sell | 1,150 | $436.00 | $501.4K | 2,009 |
| Oct 1, 2021↗ | Alter Jeffrey D. | EVP, IngenioRx & Anthem Health | Sell | 311 | $375.93 | $116.9K | 5,107 |
| Sep 4, 2021↗ | Patel Prakash R | EVP & President, DBG | Sell | 3,507 | $377.71 | $1.32M | 17,230 |
| Jul 23, 2021↗ | Schneider Ryan M. | Director | Buy | 1,300 | $384.36 | $499.7K | 4,714 |
| Jul 2, 2021↗ | Norwood Felicia F | EVP & President, GBD | Sell | 5,543 | $387.20 | $2.15M | 25,010 |
| May 24, 2021↗ | Gallina John E | EVP & Chief Financial Officer | Sell | 46,444 | $394.89 | $18.34M | 82,945 |
| May 24, 2021↗ | PERU RAMIRO G | Director | Sell | 1,308 | $398.02 | $520.6K | 9,462 |
| May 21, 2021↗ | Dixon Robert L JR | Director | Sell | 590 | $392.87 | $231.8K | 8,978 |
| May 20, 2021↗ | HILL JULIE A | Director | Sell | 1,308 | $394.00 | $515.4K | 31,213 |
| Mar 22, 2021↗ | Haytaian Peter D | EVP & President, Commercial | Sell | 59,500 | $349.20 | $20.78M | 81,744 |
| Mar 5, 2021↗ | Penczek Ronald W | SVP, Chief Accounting Officer | Sell | 2,068 | $333.94 | $690.6K | 3,137 |
| Mar 4, 2021↗ | Penczek Ronald W | SVP, Chief Accounting Officer | Sell | 67 | $323.56 | $21.7K | 5,205 |
| Mar 1, 2021↗ | BOUDREAUX GAIL | President and CEO | Sell | 37,208 | $311.49 | $11.59M | 100,300 |
| Mar 1, 2021↗ | Gallina John E | EVP & Chief Financial Officer | Sell | 11,116 | $311.49 | $3.46M | 54,320 |
| Mar 1, 2021↗ | Haytaian Peter D | EVP & President, Commercial | Sell | 14,723 | $311.49 | $4.59M | 43,951 |
| Mar 1, 2021↗ | MCCARTHY GLORIA M | EVP & Chief Administrative Off | Sell | 12,507 | $311.49 | $3.90M | 55,624 |
| Mar 1, 2021↗ | Norwood Felicia F | EVP & President, GBD | Sell | 516 | $311.58 | $160.8K | 30,553 |
| Mar 1, 2021↗ | Patel Prakash R | EVP & President, DBG | Sell | 737 | $311.61 | $229.7K | 20,737 |
| Mar 1, 2021↗ | Penczek Ronald W | SVP, Chief Accounting Officer | Sell | 860 | $311.49 | $267.9K | 5,272 |
| Mar 1, 2021↗ | STARK LEAH | EVP & CHRO | Sell | 873 | $311.63 | $272.1K | 12,885 |
| Oct 31, 2018↗ | Haytaian Peter D | EVP & President, Commercial | Sell | 1,000 | $270.00 | $270.0K | 21,544 |
ELV Insider Buying Activity
The following table shows recent insider purchases of Elevance Health Inc. (ELV) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 6, 2026↗ | COLLIS STEVEN H | director | Buy | 3,000 | $289.84 | $869.5K | 3,639 |
| Aug 21, 2025↗ | DeVore Susan D. | Director | Buy | 1,200 | $312.15 | $374.6K | 0 |
| Jul 18, 2025↗ | BOUDREAUX GAIL | President and CEO | Buy | 8,500 | $286.94 | $2.44M | 0 |
| Jul 23, 2021↗ | Schneider Ryan M. | Director | Buy | 1,300 | $384.36 | $499.7K | 4,714 |
ELV Insider Selling Activity
The following table shows recent insider sales of Elevance Health Inc. (ELV) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026↗ | Kendrick Charles Morgan JR | officer: EVP & President, Commercial | Sell | 3,196 | $284.92 | $910.6K | 11,791 |
| Feb 3, 2026↗ | Craig Ryan R | EVP & Chief HR Officer | Sell | 279 | $341.83 | $95.4K | 0 |
| Oct 3, 2025↗ | Kaye Mark | EVP & CFO | Sell | 2,895 | $340.24 | $985.0K | 0 |
| Sep 5, 2025↗ | Wessling Erin M | EVP & Chief Legal Officer | Sell | 152 | $321.59 | $48.9K | 0 |
| Apr 25, 2025↗ | Kaye Mark | EVP & CFO | Sell | 4,588 | $424.82 | $1.95M | 0 |
| Mar 11, 2025↗ | Penczek Ronald W | CAO & Controller | Sell | 443 | $415.13 | $183.9K | 0 |
| Mar 5, 2025↗ | BOUDREAUX GAIL | President and CEO | Sell | 10,396 | $395.50 | $4.11M | 0 |
| Mar 5, 2025↗ | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 2,281 | $395.50 | $902.1K | 0 |
| Mar 5, 2025↗ | Kaye Mark | EVP & CFO | Sell | 270 | $395.50 | $106.8K | 0 |
| Mar 5, 2025↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 5,725 | $395.99 | $2.27M | 0 |
| Mar 5, 2025↗ | LAVU RATNAKAR | EVP, Chief Digital & Info Off | Sell | 312 | $395.50 | $123.4K | 0 |
| Mar 5, 2025↗ | Norwood Felicia F | EVP & President,Gov Health Ben | Sell | 2,613 | $395.50 | $1.03M | 0 |
| Mar 5, 2025↗ | Penczek Ronald W | CAO & Controller | Sell | 198 | $395.50 | $78.3K | 0 |
| Nov 1, 2024↗ | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 1,649 | $414.01 | $682.7K | 17,238 |
| Nov 1, 2024↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 846 | $414.01 | $350.3K | 7,577 |
| Oct 18, 2024↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 7,417 | $432.14 | $3.21M | 8,423 |
| Oct 2, 2024↗ | Kaye Mark | EVP & CFO | Sell | 2,818 | $505.16 | $1.42M | 20,213 |
| Aug 5, 2024↗ | PERU RAMIRO G | Director | Sell | 753 | $531.52 | $400.2K | 8,744 |
| Jul 22, 2024↗ | BOUDREAUX GAIL | President and CEO | Sell | 34,000 | $500.98 | $17.03M | 159,609 |
| Jul 19, 2024↗ | Dixon Robert L JR | Director | Sell | 305 | $506.76 | $154.6K | 9,721 |
| Apr 23, 2024↗ | Norwood Felicia F | EVP & President,Gov Health Ben | Sell | 20,310 | $533.34 | $10.83M | 31,560 |
| Mar 8, 2024↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 2,432 | $500.46 | $1.22M | 15,840 |
| Mar 6, 2024↗ | Penczek Ronald W | CAO & Controller | Sell | 916 | $504.58 | $462.2K | 1,764 |
| Mar 1, 2024↗ | BOUDREAUX GAIL | President and CEO | Sell | 19,256 | $499.11 | $9.61M | 117,777 |
| Mar 1, 2024↗ | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 25,409 | $500.00 | $12.70M | 35,776 |
| Mar 1, 2024↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 1,484 | $499.11 | $740.7K | 13,764 |
| Mar 1, 2024↗ | Norwood Felicia F | EVP & President,Gov Health Ben | Sell | 4,902 | $499.11 | $2.45M | 28,541 |
| Mar 1, 2024↗ | Penczek Ronald W | CAO & Controller | Sell | 383 | $499.11 | $191.2K | 1,408 |
| Mar 1, 2024↗ | Todt Blair Williams | EVP, CLO & CAO | Sell | 3,650 | $499.11 | $1.82M | 8,465 |
| Feb 7, 2024↗ | PERU RAMIRO G | Director | Sell | 753 | $500.00 | $376.5K | 9,109 |
| Jan 3, 2024↗ | Todt Blair Williams | EVP, CLO & CAO | Sell | 397 | $480.49 | $190.8K | 12,115 |
| Dec 14, 2023↗ | Todt Blair Williams | EVP, CLO & CAO | Sell | 5,492 | $484.02 | $2.66M | 12,512 |
| Dec 1, 2023↗ | Todt Blair Williams | EVP, CLO & CAO | Sell | 1,641 | $456.06 | $748.4K | 16,029 |
| Nov 30, 2023↗ | Penczek Ronald W | CAO & Controller | Sell | 1,055 | $475.17 | $501.3K | 1,787 |
| Nov 1, 2023↗ | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 154 | $446.66 | $68.8K | 17,739 |
| Nov 1, 2023↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 79 | $446.66 | $35.3K | 15,248 |
| Oct 24, 2023↗ | Penczek Ronald W | CAO & Controller | Sell | 64 | $454.35 | $29.1K | 2,842 |
| Jul 21, 2023↗ | Dixon Robert L JR | Director | Sell | 310 | $476.71 | $147.8K | 9,638 |
| Mar 24, 2023↗ | MCCARTHY GLORIA M | EVP & Chief Administrative Off | Sell | 15,098 | $444.76 | $6.71M | 65,933 |
| Mar 9, 2023↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 2,314 | $462.22 | $1.07M | 15,327 |
| Mar 1, 2023↗ | BOUDREAUX GAIL | President and CEO | Sell | 20,085 | $468.81 | $9.42M | 135,863 |
| Mar 1, 2023↗ | Gallina John E | EVP & Chief Financial Officer | Sell | 5,237 | $468.81 | $2.46M | 63,725 |
| Mar 1, 2023↗ | Haytaian Peter D | EVP & Pres Carelon & CarelonRx | Sell | 6,076 | $468.81 | $2.85M | 17,893 |
| Mar 1, 2023↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 1,377 | $468.83 | $645.6K | 17,641 |
| Mar 1, 2023↗ | MCCARTHY GLORIA M | EVP & Chief Administrative Off | Sell | 6,047 | $468.81 | $2.83M | 66,533 |
| Mar 1, 2023↗ | Norwood Felicia F | EVP & President, GBD | Sell | 5,249 | $468.80 | $2.46M | 33,443 |
| Mar 1, 2023↗ | Penczek Ronald W | CAO & Controller | Sell | 444 | $468.82 | $208.2K | 2,882 |
| Mar 1, 2023↗ | Todt Blair Williams | EVP and Chief Legal Officer | Sell | 372 | $469.03 | $174.5K | 7,911 |
| Dec 30, 2022↗ | Norwood Felicia F | EVP & President, GBD | Sell | 1,754 | $512.97 | $899.7K | 26,684 |
| Dec 1, 2022↗ | Todt Blair Williams | EVP and Chief Legal Officer | Sell | 117 | $525.25 | $61.5K | 4,300 |
| Nov 1, 2022↗ | Haytaian Peter D | EVP & Pres Carelon & IngenioRx | Sell | 200 | $544.53 | $108.9K | 11,961 |
| Nov 1, 2022↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 79 | $544.53 | $43.0K | 14,450 |
| Jun 9, 2022↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 6,328 | $488.60 | $3.09M | 18,657 |
| Jun 6, 2022↗ | Dixon Robert L JR | Director | Sell | 420 | $497.14 | $208.8K | 9,491 |
| May 18, 2022↗ | PERU RAMIRO G | Director | Sell | 990 | $468.88 | $464.2K | 9,405 |
| Mar 10, 2022↗ | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Sell | 17,703 | $460.70 | $8.16M | 27,694 |
| Mar 1, 2022↗ | BOUDREAUX GAIL | President and CEO | Sell | 16,997 | $452.66 | $7.69M | 120,639 |
| Mar 1, 2022↗ | Gallina John E | EVP & Chief Financial Officer | Sell | 4,575 | $452.58 | $2.07M | 57,601 |
| Mar 1, 2022↗ | Haytaian Peter D | EVP & Pres., DBG & IngenioRx | Sell | 5,160 | $452.65 | $2.34M | 28,016 |
| Mar 1, 2022↗ | Kendrick Charles Morgan JR | EVP & President, Commercial | Sell | 914 | $452.94 | $414.0K | 14,529 |
| Mar 1, 2022↗ | MCCARTHY GLORIA M | EVP & Chief Administrative Off | Sell | 5,358 | $452.59 | $2.42M | 60,731 |
| Mar 1, 2022↗ | Norwood Felicia F | EVP & President, GBD | Sell | 4,014 | $452.83 | $1.82M | 28,438 |
| Mar 1, 2022↗ | Penczek Ronald W | CAO & Controller | Sell | 2,844 | $462.10 | $1.31M | 2,766 |
| Mar 1, 2022↗ | Todt Blair Williams | EVP and Chief Legal Officer | Sell | 191 | $451.50 | $86.2K | 2,534 |
| Feb 7, 2022↗ | Penczek Ronald W | CAO & Controller | Sell | 2,763 | $453.48 | $1.25M | 2,012 |
| Dec 30, 2021↗ | Norwood Felicia F | EVP & President, GBD | Sell | 1,754 | $467.15 | $819.4K | 23,256 |
| Dec 30, 2021↗ | STARK LEAH | EVP & CHRO | Sell | 482 | $467.15 | $225.2K | 12,403 |
| Dec 1, 2021↗ | Todt Blair Williams | EVP and Chief Legal Officer | Sell | 79 | $404.65 | $32.0K | 2,725 |
| Oct 28, 2021↗ | Penczek Ronald W | SVP, Chief Accounting Officer | Sell | 1,150 | $436.00 | $501.4K | 2,009 |
| Oct 1, 2021↗ | Alter Jeffrey D. | EVP, IngenioRx & Anthem Health | Sell | 311 | $375.93 | $116.9K | 5,107 |
| Sep 4, 2021↗ | Patel Prakash R | EVP & President, DBG | Sell | 3,507 | $377.71 | $1.32M | 17,230 |
| Jul 2, 2021↗ | Norwood Felicia F | EVP & President, GBD | Sell | 5,543 | $387.20 | $2.15M | 25,010 |
| May 24, 2021↗ | Gallina John E | EVP & Chief Financial Officer | Sell | 46,444 | $394.89 | $18.34M | 82,945 |
| May 24, 2021↗ | PERU RAMIRO G | Director | Sell | 1,308 | $398.02 | $520.6K | 9,462 |
| May 21, 2021↗ | Dixon Robert L JR | Director | Sell | 590 | $392.87 | $231.8K | 8,978 |
| May 20, 2021↗ | HILL JULIE A | Director | Sell | 1,308 | $394.00 | $515.4K | 31,213 |
| Mar 22, 2021↗ | Haytaian Peter D | EVP & President, Commercial | Sell | 59,500 | $349.20 | $20.78M | 81,744 |
| Mar 5, 2021↗ | Penczek Ronald W | SVP, Chief Accounting Officer | Sell | 2,068 | $333.94 | $690.6K | 3,137 |
| Mar 4, 2021↗ | Penczek Ronald W | SVP, Chief Accounting Officer | Sell | 67 | $323.56 | $21.7K | 5,205 |
| Mar 1, 2021↗ | BOUDREAUX GAIL | President and CEO | Sell | 37,208 | $311.49 | $11.59M | 100,300 |
| Mar 1, 2021↗ | Gallina John E | EVP & Chief Financial Officer | Sell | 11,116 | $311.49 | $3.46M | 54,320 |
| Mar 1, 2021↗ | Haytaian Peter D | EVP & President, Commercial | Sell | 14,723 | $311.49 | $4.59M | 43,951 |
| Mar 1, 2021↗ | MCCARTHY GLORIA M | EVP & Chief Administrative Off | Sell | 12,507 | $311.49 | $3.90M | 55,624 |
| Mar 1, 2021↗ | Norwood Felicia F | EVP & President, GBD | Sell | 516 | $311.58 | $160.8K | 30,553 |
| Mar 1, 2021↗ | Patel Prakash R | EVP & President, DBG | Sell | 737 | $311.61 | $229.7K | 20,737 |
| Mar 1, 2021↗ | Penczek Ronald W | SVP, Chief Accounting Officer | Sell | 860 | $311.49 | $267.9K | 5,272 |
| Mar 1, 2021↗ | STARK LEAH | EVP & CHRO | Sell | 873 | $311.63 | $272.1K | 12,885 |
| Oct 31, 2018↗ | Haytaian Peter D | EVP & President, Commercial | Sell | 1,000 | $270.00 | $270.0K | 21,544 |
ELV Insiders
Similar Stocks to ELV
UNH
UnitedHealth Group Incorporated
$281.12+1.48%
$251.47B
CVS
CVS Health Corporation
$76.12+0.07%
$96.78B
CI
Cigna Corporation
$267.36+0.55%
$71.02B
HUM
Humana Inc.
$165.53+1.14%
$21.12B
CNC
Centene Corporation
$34.41-0.46%
$20.67B
MOH
Molina Healthcare, Inc.
$149.63+0.30%
$7.48B
ALHC
Alignment Healthcare, Inc.
$16.94-1.05%
$3.68B
OSCR
Oscar Health, Inc.
$13.10+0.73%
$3.61B